Sunbeatables' lessons in skin cancer prevention now available...
As teachers across the country prepare for a new school year, it is now easier than ever to make sun safety a part of daily lesson...
Study helps predict lung cancer patients’ response to checkpoint...
An MD Anderson study may help researchers predict which patients with non-small cell lung cancer will respond to checkpoint blockade...
Tumor-targeting drug shows potential for treating bone...
The treatment of osteosarcoma, the most common tumor of bone, is challenging. An MD Anderson study found a drug known as bone...
Findings may help doctors ‘customize’ glioblastoma treatment
Patterns in how genes express themselves may help doctors personalize treatment for glioblastoma, the most deadly of brain cancers,...
Identifying an enzyme that keeps ovarian cancer safe from...
A study of high-grade ovarian cancer has shown the enzyme protein kinase C iota (PRKCI) to be an ovarian oncogene, suggesting PRKCI...
Symposium to address prevention, detection and treatment of...
This fall, experts from MD Anderson, the American Dental Association (ADA), the Centers for Disease Control and Prevention and the...
MD Anderson is again No. 1 in cancer care
MD Anderson Cancer Center again has been ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey...
Together, chemo and proton therapy lengthen survival for...
For patients with advanced, inoperable stage 3 lung cancer, chemotherapy and a specialized form of radiation treatment known...
MD Anderson is first in Texas to be accredited to train...
Since 2006, MD Anderson’s Tobacco Treatment Program (TTP) has been providing tobacco cessation services to patients and employees...
Metastatic colorectal cancer patients with a certain...
A practice-changing clinical trial conceived and led by MD Anderson investigators showed that metastatic colorectal cancer patients...